Medication Experiences II

A special issue of Pharmacy (ISSN 2226-4787). This special issue belongs to the section "Pharmacy Practice and Practice-Based Research".

Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 9024

Special Issue Editor


E-Mail Website
Guest Editor
College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA
Interests: Information processing and decision making related to the provision, use, and evaluation of drug products and pharmacist services
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues, 

In light of the positive response to our first Special Issue on Medication Experiences published in 2021 (https://www.mdpi.com/journal/pharmacy/special_issues/Medication_Experiences), I invite you to submit a manuscript to the Special Issue “Medication Experiences” in the journal Pharmacy—an open-access journal with a focus on pharmacy education and practice.

As an example, you may wish to take a look at previous Special Issues: https://www.mdpi.com/journal/pharmacy/special_issues 

Submissions within this Special Issue will be processed and published free of charge. If the Special Issue publishes more than 10 papers, the publisher will print a book edition. The book would be made available, in digital format (for free) and paperback copies (ordered via Amazon), on the MDPI platform (http://books.mdpi.com). 

Pharmacy (ISSN 2226-4787) is an international scientific open access journal on pharmacy education and practice published quarterly online by MDPI. The journal has already been indexed by PubMed, ESCI (Emerging Sources Citation Index), and Web of Science. Furthermore, Pharmacy is a member of the Committee on Publication Ethics (COPE), and, accordingly, submissions are peer reviewed rigorously to ensure that they conform to the highest standards in their field. 

For the Special Issue on “Medication Experiences” we seek a full breadth of manuscripts addressing topics including, but not limited to: (1) individuals’ subjective lived experience of taking medications in their daily lives; (2) symbolism that medications hold for people; (3) meanings of medications for people; (4) positive or negative bodily effects people experience from medications; (5) dealing with the unremitting nature of chronic medication use; (6) exerting control over their medications; (7) medications as a life savior or a life burden; (8) beliefs, information processing, and decision making about medications; (9) helpful service designs for using medications; and (10) patient-reported outcomes regarding medications. We seek manuscripts of all types including: reviews, commentaries, idea papers, case studies, demonstration studies, and research studies. 

The overall goal of this Special Issue on “Medication Experiences II” is to give the reader a state-of-the-art synopsis of the medication experience domain at this point in time. To accomplish this goal, we seek papers that address the social, psychosocial, political, legal, historic, clinical, and economic factors that are associated with medication experiences. Papers that translate concepts from other domains into the medication experiences realm will be instructive to our audience and are welcome for this Special Issue. 

Please note that we have framed this Special Issue using ideas published by experts in the medication experience domain, including: 

Camporesi, Silvia. “Pharmacopoeia, or How Many Pills Do We Take in a Lifetime?” Humanities and Health, April 28, 2011, King’s College London. 

Cervasev, Alina, Sonja Kuftinec, Ryan M. Bortz, Jon C. Schommer, and Paul L. Ranelli, “Using Theater as an Educational Tool for Understanding Medication Experiences from the Patient Perspective,” American Journal of Pharmaceutical Education, Special Issue: The Arts In Health Professions Education, 2020, Vol. 84, No. 4, Article 7606, 459–465. 

Cipolle, Robert J., Linda M. Strand, and Peter C. Morley, “The Patient’s Medication Experience,” in Pharmaceutical Care Practice, The Clinician’s Guide, Second Edition, 2004, The McGraw-Hill Companies, Inc., New York, 102–117. 

Mohammed, Mohammed, Rebekah J. Moles, and Timothy F. Chen, “Medication-related burden and patients’ lived experience with medicine: a systematic review and metasythesis of qualitative studies,” BMJ Open, 2016, Vol. 6, e010035. Doi:10.1136/bmjopen-2015-010035. 

Shoemaker, Sarah J. and Djenane Ramalho de Oliveira. “Understanding the Meaning of Medications for Patients: The Medication Experience,” Pharm World Sci, 2009, Vol. 30: 86–91. 

Shoemaker, Sarah J., Djenane Ramalho de Oliveira, Mateus Alves, and Mollie Ekstrand, “The Medication Experience: Preliminary Evidence of Its Value for Patient Education and Counseling on Chronic Medications,” Patient Education and Counseling, 2011, Vol. 83, No. 3, 443–450. 

Sanchez, Luz Dalia, “Medication Experiences of Hispanic People Living with HIV/AIDS,” INNOVATIONS in pharmacy, 2010, Vol. 1, No. 1, Article 6 (9 pages). 

Singh, Reshmi L., Jon C. Schommer, Marcia M. Worley, and Cynthia Peden-McAlpine, “Antidepressant Use Amongst College Students’: Findings of a Phenomenology Study,” INNOVATIONS in pharmacy, 2012, Vol. 3, No. 2, Article 76, 13 pages. 

We will certainly consider papers that use other frameworks, but wanted to let you know about the foundational context that we will be using as we construct this Special Issue. 

Thank you for considering this invitation.

Prof. Dr. Jon Schommer
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Medication
  • Experiences
  • Beliefs
  • Decision making
  • Person

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

22 pages, 1021 KiB  
Article
Nonmedical Prescription Opioid Use among a Sample of College Students: Prevalence and Predictors
by Lisa L. Weyandt, Bergljót Gyda Gudmundsdottir, Emily Shepard, Leslie Brick, Ashley Buchanan, Christine Clarkin, Alyssa Francis and Marisa Marraccini
Pharmacy 2021, 9(2), 106; https://doi.org/10.3390/pharmacy9020106 - 28 May 2021
Cited by 4 | Viewed by 5108
Abstract
Nonmedical use of prescription opioid medication (NMPO) in the United States is a public health crisis, resulting in high rates of emergency room visits, morbidity, and mortality. The purpose of this study was to explore prevalence estimates and correlates of NMPO among a [...] Read more.
Nonmedical use of prescription opioid medication (NMPO) in the United States is a public health crisis, resulting in high rates of emergency room visits, morbidity, and mortality. The purpose of this study was to explore prevalence estimates and correlates of NMPO among a convenience sample of college students in the northeast and southeast regions of the US to help generate directions for future research. Motivations for misuse, age of onset, access, concomitant substance use, and individual factors were investigated among a sample of undergraduate students from two universities. Participants (N = 847) completed a battery of various self-report measures. Findings revealed that 7.7% (Southeastern University) and 12.8% of students (Northeastern University) reported lifetime NMPO, whereas past-month NMPO was reported by 0.8% and 0.9% of participants, respectively. Lifetime history of regularly using alcohol, nonmedical use of benzodiazepine medication, nonmedical use of prescription stimulants, symptoms of depression and anxiety, and executive functioning (i.e., metacognition and behavioral regulation) were significantly related to lifetime history of NMPO in this college sample. These findings offer several potential subsequent lines of investigation regarding the associations between various demographic and psychological factors and NMPO. Future research is needed to help identify college students who are at risk of NMPO. Full article
(This article belongs to the Special Issue Medication Experiences II)
Show Figures

Figure 1

9 pages, 221 KiB  
Article
Predisposing, Enabling, and Need Factors Associated with the Choice of Pharmacy Type in the US: Findings from the 2015/2016 National Consumer Survey on the Medication Experience and Pharmacists’ Roles
by Mohamed Rashrash, Suhila Sawesi, Jon C. Schommer and Lawrence M. Brown
Pharmacy 2021, 9(2), 72; https://doi.org/10.3390/pharmacy9020072 - 28 Mar 2021
Cited by 2 | Viewed by 3249
Abstract
Background: Knowing the type of pharmacy used by the patient is meaningful to the pharmacist. Previous studies have assessed different factors predicting the kind of pharmacy selection and reached inconsistent findings. Objectives: To identify patient and health-related factors associated with pharmacy type selection. [...] Read more.
Background: Knowing the type of pharmacy used by the patient is meaningful to the pharmacist. Previous studies have assessed different factors predicting the kind of pharmacy selection and reached inconsistent findings. Objectives: To identify patient and health-related factors associated with pharmacy type selection. Methods: The Andersen Behavioral Model of Health Service Use was used to organize the selection of patient characteristics and categorize them as predisposing, enabling, and need factors. The dependent variable was the type of pharmacy used. Logistic regression was used to predict the association between patient-related characteristics and the type of pharmacy used. Results: Older age respondents were less likely to use independent pharmacies (OR = 0.992) and more likely to use mail pharmacy services (OR = 1.026). Highly educated people showed higher use of chain and mail pharmacies (OR = 1.272, 1.185, respectively) and less tendency to use the independent, supermarket, and prescription-only pharmacy types. Men were less likely to use chain pharmacies (OR = 0.932) and more likely to use supermarket pharmacies than women. Patients who use Medication Therapy Management (MTM) services had higher odds of using independent and supermarket pharmacies (OR = 2.808, 1.689, respectively). Patients with a higher number of chronic diseases and experienced side effects of medications were more likely to use independent pharmacies (OR for number of disease = 1.097 and for side effects = 1.095). Conclusions: This study’s findings identify characteristics associated with selecting certain pharmacy settings and direct future research to include other predictors encompassing beliefs, attitudes, and other social factors. Full article
(This article belongs to the Special Issue Medication Experiences II)
Back to TopTop